Hunterdon Medical Center
- Type
- Teaching hospital
- Where
- Flemington, NJ
- Medicare CCN
- 310005
- Received
- $649,730 in 30 records, 2024 ($46,653 general, $603,077 research)
- Source
- CMS Open Payments search ↗
On this site
- Nonprofit contractor: HUNTERDON MEDICAL CENTER Fuzzy (name and state)
- Plan sponsor: HUNTERDON MEDICAL CENTER Fuzzy (name and state)
- Federal award recipient: HUNTERDON MEDICAL CENTER Fuzzy (name and state)
- Lobbying client: HUNTERDON MEDICAL CENTER Fuzzy (name and state)
- Nonprofit: HUNTERDON MEDICAL CENTER Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2024 | General payment | 9 | $46,653 |
| 2024 | Research payment | 21 | $603,077 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| PFIZER INC. | 21 | $603,077 | 2024 |
| Olympus America Inc. | 2 | $30,736 | 2024 |
| Stryker Corporation | 5 | $15,632 | 2024 |
| Siemens Medical Solutions USA, Inc. | 1 | $199 | 2024 |
| Baxter Healthcare | 1 | $85 | 2024 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 21 | $603,077 |
| Debt forgiveness | 5 | $31,076 |
| Long term medical supply or device loan | 4 | $15,577 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | Stryker Corporation | $4,097 | Long term medical supply or device loan | In-kind items and services | Connected OR Hub Device, ENDOSCOPY | 2024 | |
| 2024-12-31 | Stryker Corporation | $4,097 | Long term medical supply or device loan | In-kind items and services | Connected OR Hub Device, ENDOSCOPY | 2024 | |
| 2024-12-31 | Stryker Corporation | $4,045 | Long term medical supply or device loan | In-kind items and services | NA Device, INSTRUMENTS | 2024 | |
| 2024-12-31 | Stryker Corporation | $3,336 | Long term medical supply or device loan | In-kind items and services | Crossfire Device, ENDOSCOPY | 2024 | |
| 2024-12-31 | Siemens Medical Solutions USA, Inc. | $199 | Debt forgiveness | In-kind items and services | 2024 | ||
| 2024-12-31 | Stryker Corporation | $55 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-12-28 | PFIZER INC. | $21,039 | Research payment | Cash or cash equivalent | A PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM | 2024 | |
| 2024-12-18 | PFIZER INC. | $58,957 | Research payment | Cash or cash equivalent | A PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM | 2024 | |
| 2024-11-23 | PFIZER INC. | $49,456 | Research payment | Cash or cash equivalent | A PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM | 2024 | |
| 2024-10-23 | Baxter Healthcare | $85 | Debt forgiveness | In-kind items and services | Hillrom - MetaNeb System Device, Airway Clearance Device | 2024 | |
| 2024-10-22 | PFIZER INC. | $1,738 | Research payment | Cash or cash equivalent | A PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM | 2024 | |
| 2024-09-28 | PFIZER INC. | $75 | Research payment | Cash or cash equivalent | A PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM | 2024 | |
| 2024-09-27 | PFIZER INC. | $18,985 | Research payment | Cash or cash equivalent | A PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM | 2024 | |
| 2024-08-22 | PFIZER INC. | $49,754 | Research payment | Cash or cash equivalent | A PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM | 2024 | |
| 2024-07-30 | Olympus America Inc. | $922 | Debt forgiveness | In-kind items and services | EVIS EXERA III COLONOVIDEOSCOPE Device, Gastroenterology | 2024 | |
| 2024-07-23 | PFIZER INC. | $8,347 | Research payment | Cash or cash equivalent | A PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM | 2024 | |
| 2024-06-25 | PFIZER INC. | $27,959 | Research payment | Cash or cash equivalent | A PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM | 2024 | |
| 2024-06-07 | PFIZER INC. | $31,732 | Research payment | Cash or cash equivalent | A PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM | 2024 | |
| 2024-05-30 | Olympus America Inc. | $29,814 | Debt forgiveness | In-kind items and services | Bovie Device, Urology Gynecology | 2024 | |
| 2024-05-18 | PFIZER INC. | $49,140 | Research payment | Cash or cash equivalent | A PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM | 2024 | |
| 2024-05-01 | PFIZER INC. | $43,098 | Research payment | Cash or cash equivalent | A PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM | 2024 | |
| 2024-04-16 | PFIZER INC. | $35,752 | Research payment | Cash or cash equivalent | A PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM | 2024 | |
| 2024-04-09 | PFIZER INC. | $40,887 | Research payment | Cash or cash equivalent | A PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM | 2024 | |
| 2024-04-02 | PFIZER INC. | $33,423 | Research payment | Cash or cash equivalent | A PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM | 2024 | |
| 2024-03-28 | PFIZER INC. | $77,228 | Research payment | Cash or cash equivalent | A PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM | 2024 | |
| 2024-03-27 | PFIZER INC. | $27,990 | Research payment | Cash or cash equivalent | A PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM | 2024 | |
| 2024-03-02 | PFIZER INC. | $11,797 | Research payment | Cash or cash equivalent | A PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM | 2024 | |
| 2024-03-01 | PFIZER INC. | $3,828 | Research payment | Cash or cash equivalent | A PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM | 2024 | |
| 2024-01-24 | PFIZER INC. | $4,785 | Research payment | Cash or cash equivalent | A PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM | 2024 | |
| 2024-01-06 | PFIZER INC. | $7,099 | Research payment | Cash or cash equivalent | A PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM | 2024 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Flemington, NJ, county Hunterdon County, NJ, state New Jersey; placed by its city name.
| Measure | Place (city or town) Flemington, NJ | County Hunterdon County, NJ | State New Jersey |
|---|---|---|---|
| Population B01003 | 4,896 | 130,160 | 9,343,809 |
| Population, 2020 census P1 | 4,876 | 128,947 | 9,288,994 |
| Median age B01002 | 34.2 | 46.1 | 40.1 |
| Under 18 B01001 | 19.6% | 19.1% | 21.8% |
| 65 and over B01001 | 13.7% | 20.8% | 17.2% |
| Households B11001 | 2,119 | 50,860 | 3,507,701 |
| Foreign born B05002 | 31.1% | 10.6% | 23.9% |
| Median household income B19013 | $69,978 | $141,715 | $103,556 |
| Median family income B19113 | $112,604 | $171,597 | $127,025 |
| Per capita income B19301 | $45,921 | $72,227 | $54,253 |
| Poverty rate B17001 | 11.8% | 4.0% | 9.7% |
| Unemployment rate B23025 | 1.2% | 4.6% | 6.3% |
| Civilian labor force B23025 | 2,781 | 70,526 | 5,003,179 |
| Mean commute (minutes) B08013 | 22.7 | 33.0 | 30.5 |
| Bachelor's degree or higher B15003 | 39.8% | 57.4% | 43.6% |
| Housing units B25001 | 2,191 | 52,115 | 3,791,354 |
| Owner-occupied B25003 | 34.1% | 85.1% | 63.8% |
| Renters B25003 | 65.9% | 14.9% | 36.2% |
| Median home value B25077 | $400,600 | $517,200 | $454,400 |
| Median gross rent B25064 | $1,532 | $1,687 | $1,720 |
| White, not Hispanic B03002 | 56.1% | 79.9% | 50.9% |
| Black B03002 | 2.7% | 2.4% | 12.2% |
| Hispanic or Latino B03002 | 34.1% | 9.3% | 22.5% |
| Asian B03002 | 6.3% | 4.9% | 10.0% |
| American Indian and Alaska Native B03002 | 0.0% | 0.0% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Flemington, NJ.
Comments